Penelope Przekop PDC Pharma Strategy

Penelope Przekop, CEO of PDC Pharma Strategy, is a quality assurance (QA) and corporate compliance executive with over 30 years of industry experience across GxPs. Before founding her consulting firm, she held leadership roles at Covance, Wyeth (now Pfizer), and Johnson & Johnson, following earlier positions in preclinical research, regulatory affairs, and QA positions of increasing responsibility at Hoechst-Roussel and Novartis. 

She developed and led the first global pharmacovigilance quality and compliance departments at both Wyeth and J&J and has built and overseen multiple global GxP quality management systems, QA functions, audit programs, and regulatory inspection readiness programs. Penelope has conducted numerous GxP mock inspections and facilitated and supported numerous regulatory inspections. 

She holds an MS in Quality Systems from Kennesaw State University and a BS in Biology from Louisiana State University. Penelope has authored quality management-related books published by McGraw-Hill and Productively Press.